Search results for: clinical trial

Refine your Search
Apply several filters to get precise search results
Showing opportunity 1 - 10 of 1,954
  • Research Clinical Trial Services

    Type : Bid Notification

    Due : 17 May, 2024 (in 14 days)
    Posted : 6 days ago
    Started : 25 Apr, 2024 (7 days ago)

    Research Clinical Trial Services Project Description :Proposal for oversight of clinical trial compliant with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline for Good Clinical Practice (GCP) E6(R2), Health Canada’s Food and Drug Regulations, Part C, Division 5, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans – TCPS 2 (2022) and other applicable regulations

    From: MerX (Federal)

  • NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)

    Type : Bid Notification

    Due : 14 Jan, 2027 (in about 2 years)
    Posted : 14 days ago
    Started : 03 Apr, 2024 (29 days ago)

    14, 2027 (closing in 987 days) Available Funding Topics PAR-24-099: NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) × NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Purpose This Notice of Funding Opportunity (NOFO) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement

    From: Small Business Innovation Research (Federal)

  • Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

    Type : Bid Notification

    Due : 17 Oct, 2024 (in 5 months)
    Posted : 12 months ago
    Started : 13 Apr, 2023 (12 months ago)

    The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.Link

    From: Ohio Department of Higher Education (Higher Education)

  • Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)

    Type : Bid Notification

    Due : 21 Jun, 2024 (in 1 month)
    Posted : 12 months ago
    Started : 13 Apr, 2023 (12 months ago)

    Document Type:Grants NoticeFunding Opportunity Number:PAR-23-098Funding Opportunity Title:Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:HealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.172 -- Human Genome Research 93.242 -- Mental Health Research GrantsCost Sharing or Matching

    From: Ohio Department of Higher Education (Higher Education)

  • Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional)

    Type : Bid Notification

    Due : 26 Jul, 2024 (in 2 months)
    Posted : 8 months ago
    Started : 01 Sep, 2023 (8 months ago)

    Document Type:Grants NoticeFunding Opportunity Number:RFA-NR-24-001Funding Opportunity Title:Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:EducationHealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.313 -- NIH Office of Research on Women's Health 93.361 -- Nursing

    From: Ohio Department of Higher Education (Higher Education)

  • NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)

    Type : Bid Notification

    Due : 06 Sep, 2026 (in about 2 years)
    Posted : 14 days ago
    Started : 03 Apr, 2024 (29 days ago)

    Renewal applications of SBIR Phase II awards (i.e., SBIR Phase IIB) to conduct Phase I and II clinical studies should be submitted to NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44).

    From: Small Business Innovation Research (Federal)

  • NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)

    Type : Bid Notification

    Due : 06 Sep, 2026 (in about 2 years)
    Posted : 14 days ago
    Started : 03 Apr, 2024 (29 days ago)

    Renewal applications of SBIR Phase II awards (i.e., SBIR Phase IIB) to conduct Phase I and II clinical studies should be submitted to NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44).

    From: Small Business Innovation Research (Federal)